Showing results (2291-2300 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|November 1, 1990
An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosaA van Eeden, R H Schotborgh, G N TytgatClinical Therapeutics|April 19, 2011
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claimsFeng Zeng, Chieh-I Chen, Vera Mastey, et al.Clinical Therapeutics|May 24, 2011
Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdomAvani D Joshi, John A Carter, Marc F Botteman, et al.Clinical Therapeutics|May 24, 2011
Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational studyHarma Israël-Bultman, Jacob Hyllested-Winge, Marcin Kolaczynski, et al.Clinical Therapeutics|June 28, 2011
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetesGeorge DaileyClinical Therapeutics|June 28, 2011
Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteersMichael Derks, Hitoshi Kawamura, Markus Abt, et al.Clinical Therapeutics|June 28, 2011
Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trialsAnthony R Godfrey, Jennifer Digiacinto, Matthew W DavisClinical Therapeutics|June 28, 2011
Impact of drug label changes on propofol use in pediatrics for moderate conscious sedationPamela C Heaton, Joseph Schuchter, Carole M Lannon, et al.Clinical Therapeutics|June 28, 2011
Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteersFrancisco E Estevez-Carrizo, Susana Parrillo, Mónica Cedres Ercoli, et al.Clinical Therapeutics|January 4, 2011
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.Pageof 680